Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
about
Autophagy, mitochondria and oxidative stress: cross-talk and redox signallingMitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model.Mitochondrial biology and Parkinson's diseaseCytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathiesAnkyrin repeat and BTB/POZ domain containing protein-2 inhibits the aggregation of alpha-synuclein: implications for Parkinson's diseaseIdentification of licopyranocoumarin and glycyrurol from herbal medicines as neuroprotective compounds for Parkinson's diseaseThe cybrid model of sporadic Parkinson's disease.Mitochondrial quality, dynamics and functional capacity in Parkinson's disease cybrid cell lines selected for Lewy body expression.Cybrid models of Parkinson's disease show variable mitochondrial biogenesis and genotype-respiration relationshipsRelationships among molecular genetic and respiratory properties of Parkinson's disease cybrid cells show similarities to Parkinson's brain tissuesReduced axonal transport in Parkinson's disease cybrid neurites is restored by light therapy.Chronic, low-dose rotenone reproduces Lewy neurites found in early stages of Parkinson's disease, reduces mitochondrial movement and slowly kills differentiated SH-SY5Y neural cells.Proteomic characterization of an isolated fraction of synthetic proteasome inhibitor (PSI)-induced inclusions in PC12 cells might offer clues to aggresomes as a cellular defensive response against proteasome inhibition by PSI.New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.Lysosomal function in macromolecular homeostasis and bioenergetics in Parkinson's disease.Distinct effects of rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on cellular bioenergetics and cell death.A53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degenerationRole and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.Mitochondria in neurodegeneration.Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence.Estrogen actions on mitochondria--physiological and pathological implications.Mitochondrial dynamics in Parkinson's disease.Tickled PINK1: mitochondrial homeostasis and autophagy in recessive Parkinsonism.The impact of mitochondrial DNA and nuclear genes related to mitochondrial functioning on the risk of Parkinson's disease.Cross-talk between mitochondria and proteasome in Parkinson's disease pathogenesis.Mitochondrial preconditioning: a potential neuroprotective strategy.Neurofilamentopathy in neurodegenerative diseasesBioenergetics and metabolism: a bench to bedside perspective.A cybrid cell model for the assessment of the link between mitochondrial deficits and sporadic Parkinson's disease.Mitochondrial fusion/fission, transport and autophagy in Parkinson's disease: when mitochondria get nasty.The Universal Non-Neuronal Nature of Parkinson's Disease: A Theory.
P2860
Q24608960-80B045B9-D65C-48D6-AEDB-F20938EE1820Q24634806-D439EC4C-E546-4643-9C55-6478A374370BQ26824090-4B20B506-CCC3-4DBF-8A92-141B8B3842FBQ26859496-24C930C5-5ED9-4477-A41A-6ABC266B5358Q28505185-F4EB7F7D-D26E-4E16-8122-EB3EAA3C30B8Q28539943-7F51456F-58AD-41C8-BD55-E5F65E6EC075Q28751790-488576F0-D14B-42AD-8431-2A19E91DAC82Q30422362-B3C11355-B3EE-4752-B0FE-1F6CD8BF18C3Q30433981-C00816BC-5E37-4A5B-8D00-B86AF550B4A5Q30437451-D64F3A93-45AD-47DD-8282-377D86643248Q30439165-3E290D86-74E8-4723-AE52-577589B50D21Q30440337-A2E77FB2-21C9-4EEA-A35D-0E363DB24B19Q30479870-F078A3CD-723A-40CC-8F51-233D9A0AA6EDQ33783000-68656343-8768-43A3-B2BF-563B369DBA00Q33843073-9274BB06-5C79-4981-B639-EB547DAB92A1Q34412601-E4CEBD08-7D15-40AC-8080-0FA459D33BD8Q34989985-EAB0E0F5-7064-4A13-937E-4C8B079EF2B1Q35958359-64E08AD2-CAD9-4779-BB66-4FBAFF5B7885Q36745271-8C88D145-5847-4954-8C2A-32C4E6A26193Q36813613-013B1C2E-5674-4028-BB9A-37A64ED588AFQ37197561-86776012-E6F0-4852-9470-F9C6A398DD00Q37364337-E98A69AE-32FF-4492-A410-3954E83733D4Q37466094-13EF2E69-6495-4859-AD5D-775CE9A8EEAEQ37583410-72F54E05-8962-4A6E-B847-1E4DF2B3190AQ37767600-FCA83434-E144-45B0-AF2F-A675ED7CB003Q37788545-D6F7AC3C-32D4-4D5B-9832-980F0DF23002Q37931629-ADA28C05-5670-456A-8723-B20B93651F47Q38770543-FA70AEB1-A73C-4F2E-BFEE-10811213E436Q38915128-D92E4139-5706-42DE-BFC7-67A9E2927DF1Q41850035-A349A3DB-F378-435C-83BD-DA597CB17190Q46540528-3A9ED6FD-0F4C-40E0-9C7E-5267303D8BED
P2860
Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
@ast
Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
@en
type
label
Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
@ast
Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
@en
prefLabel
Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
@ast
Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
@en
P2093
P1476
Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies
@en
P2093
James P Bennett
M Kathleen Borland
Patricia A Trimmer
Paula M Keeney
W Davis Parker
P304
P356
10.1046/J.1471-4159.2003.02168.X
P407
P577
2004-02-01T00:00:00Z